First Huda, Now Morphe Faces Proposed Nationwide Class Action Over Eyeshadow Colors
Executive Summary
A class action in California federal court targets Morphe Cosmetics for the sale and marketing of eyeshadows containing unapproved colors for eye-area use that three consumers say inflicted physical injury. They seek to represent consumers nationwide, citing breach of warranties, negligence, false advertising, and other claims.
You may also be interested in...
ColourPop Suit Challenging Unapproved Colorants In Eye Makeup Goes To Ninth Circuit
“The Court can’t make a decision the FDA itself did not make,” wrote US district judge Trina Thompson in her 7 September order dismissing plaintiff Kacey Wilson’s second amended complaint against ColourPop. At issue is the company’s use of color additives in eye makeup products that the US FDA has not approved for eye-area use, but also has not determined are likely to cause injuries, according to the court.
CIR Hair-Dye Assessments Strike On Unapproved Colorant Uses; FDA’s Cosmetics Office Has Eye On It
Cosmetic Ingredient Review’s independent experts considered hair dyes in unapproved applications in its 163rd meeting, prompting commentary from US FDA leadership on hand.
Huda Beauty To Settle Class Action Over Eyeshadows ‘Not Intended For The Eye Area'
US consumers who purchased Neon Obsession pressed pigment palettes may be entitled to refunds under a settlement preliminarily approved in California’s Central District. Plaintiffs say Huda promoted Neon Obsession as eyeshadow despite use of color additives not approved by the FDA for eye-area use, an issue that cannot be cured by a “buried” disclaimer on product packaging.